drugset / Trial / NCT00156078

A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

NCT00156078

Phase 4 Completed 450 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A study of pregabalin efficacy and safety in a racially and culturally diverse group of subjects with painful diabetic peripheral neuropathy (DPN).

Timeline

Start
2005-01
Primary completion
Completion
2007-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg
Subject Pregabalin Small molecule 600 mg